KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Interest Coverage Ratio (2016 - 2023)

Supernus Pharmaceuticals (SUPN) has disclosed Interest Coverage Ratio for 13 consecutive years, with 19.33 as the latest value for Q2 2023.

  • Quarterly Interest Coverage Ratio fell 408.31% to 19.33 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was 14.94 through Mar 2024, down 300.91% year-over-year, with the annual reading at 2.18 for FY2023, 133.44% down from the prior year.
  • Interest Coverage Ratio for Q2 2023 was 19.33 at Supernus Pharmaceuticals, down from 3.44 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 21.54 in Q4 2022, with the low at 19.33 in Q2 2023.
  • Average Interest Coverage Ratio over 5 years is 4.58, with a median of 5.87 recorded in 2021.
  • The sharpest move saw Interest Coverage Ratio soared 1996.02% in 2022, then crashed 408.31% in 2023.
  • Over 5 years, Interest Coverage Ratio stood at 7.07 in 2019, then dropped by 0.17% to 7.05 in 2020, then plummeted by 85.43% to 1.03 in 2021, then skyrocketed by 1996.02% to 21.54 in 2022, then crashed by 189.73% to 19.33 in 2023.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 19.33, 3.44, and 21.54 for Q2 2023, Q1 2023, and Q4 2022 respectively.